NanoString Technologies, Inc. provided revenue guidance for the fourth quarter of 2022. The company expects total fourth quarter revenue of $33 million to $35 million.
NanoString Technologies, Inc.
Equities
NSTGQ
US63009R1095
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0922 USD | -7.80% | -24.18% | -87.68% |
05-22 | First Amended Disclosure Statement Approved for NanoString Technologies, Inc. | CI |
05-07 | Bruker's NanoString Secures Patent Case Win in Germany | MT |
1st Jan change | Capi. | |
---|---|---|
-87.68% | 4.44M | |
-7.38% | 177B | |
-0.46% | 108B | |
-6.98% | 65.55B | |
+2.65% | 50.66B | |
+5.27% | 42.58B | |
+5.73% | 40.74B | |
+19.92% | 31.07B | |
+16.57% | 25.45B | |
-7.00% | 23.85B |
- Stock Market
- Equities
- NSTGQ Stock
- News NanoString Technologies, Inc.
- NanoString Technologies, Inc. Provides Revenue Guidance for the Fourth Quarter of 2022